GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | CCL5 | multiple interactions | EXP | | 6480464 | CTD | Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CCL5 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] | PMID:16908450 PMID:27568862 | CCL5 | increases expression | ISO | Ccl5 (Mus musculus) | 6480464 | CTD | Dexamethasone results in increased expression of CCL5 mRNA | PMID:21041162 | CCL5 | multiple interactions | ISO | Ccl5 (Rattus norvegicus) | 6480464 | CTD | Dexamethasone inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4]; Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] | PMID:18083043 | CCL5 | multiple interactions | ISO | Ccl5 (Mus musculus) | 6480464 | CTD | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA; Dexamethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CCL5 mRNA]; Dexamethasone inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; Dexamethasone inhibits the reaction [TNF protein results in increased expression of CCL5 protein] | PMID:10495789 PMID:23503329 PMID:31751647 | |
Go Back to source page | Continue to Ontology report |